Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

EBGLYSS is an FDA-approved drug for treating moderate-to-severe eczema by targeting IL-13, offering relief to patients ...

The study, funded by the National Institutes of Health, supports no change to surgical technique for trichiasis management.

The US Food and Drug Administration (FDA) has approved the targeted interleukin (IL)-13 inhibitor lebrikizumab (Ebglyss) for ...

The FDA approved lebrikizumab (Ebglyss) for treating atopic dermatitis in adults and children ages 12 years and up, drugmaker ...

In some, it can happen in and around the eyes, eyelids ... and cancer or treatments like radiation or medications to prevent the rejection of transplanted organs—all of which lower immunity and ...

When Nancy Greeley was in her 50s, her sister, an infectious-disease specialist at the University of Rochester, told her to ...

If the pain doesn't resolve with at-home treatment, gets worse or is accompanied by vision ... that can result from infection include blepharitis, which affects the eyelids, and keratitis, which ...

Trachomatous trichiasis, a potentially blinding condition where inward-turned eyelashes scratch the front of the eye, can ...

The US food and Drug Administration has approved lebrikizumab for treatment of atopic dermatitis in adults and children ages ...

">On a normal eyelid (left), eyelashes are turned outward away from the cornea. Eyelids affected by trichiasis (center) have ...